New device may reduce repeat breast cancer surgeries

September 12, 2012 by Kathleen Doheny, Healthday Reporter
New device may reduce repeat  breast cancer surgeries
Tool could help surgeons determine if all cancerous tissue is excised in lumpectomy, study says.

(HealthDay)—A new device meant to help surgeons determine in the operating room if they have removed all cancerous breast cancer tissue may help reduce repeat surgeries after lumpectomy without compromising cosmetic effects, according to a new study.

The device, called MarginProbe, emits an electric field and senses a return signal from the tissue examined. provides a different electromagnetic signature than normal tissue, the researchers explained.

"This can potentially decrease having to go back to the operating room and with no real effect on your [cosmetic] outcome," said study leader Dr. Susan Boolbol, chief of at Beth Israel Medical Center, in New York City.

The study of nearly 500 patients undergoing breast-conserving surgery found little difference in the volume of tissue removed when the device was used compared to traditional detection methods.

"The reality is, most of the time we leave the and we don't know if we have a clear margin [with all cancer removed] or not," Boolbol said. Doctors wait for the pathology report to find that out, which can take a week or two. With the new device, the wait time is about five minutes.

"Everything still goes through pathology," Boolbol said. But the MarginProbe is another tool that might help reduce the odds of needing a subsequent surgery, she said.

Boolbol is scheduled to present the findings Thursday at the 's symposium in San Francisco.

In June, the radiation-free device won the blessing of a U.S. advisory panel. The FDA usually follows the advisory panel's recommendations, so device approval is anticipated.

For the study, Boolbol and her colleagues randomly assigned 495 to receive the MarginProbe after or not receive it. Of those, 161 had early cancer known as in situ. The others had invasive cancers.

Where the device detected cancer cells near the edge or surface of the sample examined, surgeons removed additional tissue in the same procedure.

Typically, about 40 percent of lumpectomy patients need another surgery because of the difficulty distinguishing between healthy and cancerous cells in tissue around the tumor.

"We looked at whether we could lower the [repeat surgery] rate by using this device," Boolbol said. The patients were followed for two months to see if they needed a repeat surgery. For those with ductal carcinoma in situ, 13 percent of the probe group needed a repeat surgery, compared to 37 percent of the control group.

Among women with invasive breast cancer, 17 percent in the device group and 33 percent in the comparison group required more surgery.

Looking at the volume of tissue excised, the researchers said not much more tissue was removed when the device was used compared to removed in the initial and subsequent surgeries among the control-group patients, Boolbol said.

Dr. Laura Kruper, director of the Cooper Finkel Women's Health Center and co-director of the breast cancer program at City of Hope Comprehensive Cancer Center in Duarte, Calif., said the device looks promising. However, she thinks more research is needed.

"I would like to see it [used] in a larger population," she said. If the results are repeated in larger studies, it could be a welcome addition to doctors' techniques, she said.

The expected cost of the MarginProbe in the United States, if approved, is not yet known, said Michael Graffeo, a spokesman for its maker, Dune Medical Devices. In Europe, where the device is available, each probe (one per patient) sells for about 600 euros or $760, he said. This is much less than the cost of re-operation, he noted.

The is also being studied for use with prostate cancer, the company said.

Data and conclusions presented at meetings should be considered preliminary until published in a peer-reviewed medical journal.

Explore further: Fewer women need repeat breast cancer surgeries with new service at University of Michigan

More information: To learn more about breast cancer surgery, visit the American Cancer Society.


Related Stories

Fewer women need repeat breast cancer surgeries with new service at University of Michigan

February 28, 2012
Nearly one in three women who have breast cancer surgery will need to return to the operating room for additional surgery after the tumor is evaluated by a pathologist.

Researchers examine 21-year series of nipple sparing mastectomy cases and find no cancers

October 27, 2011
A new study suggests some women needing a lumpectomy or mastectomy to treat their breast cancer have another potential option that is safe and effective, say researchers at Georgetown. They say the procedure known as a nipple ...

Ultrasound-guided surgery is best way to remove breast tumours

March 23, 2012
The use of ultrasound-guided surgery to remove tumours from women who have palpable breast cancer is much more successful than standard surgery in excising all the cancerous tissue while sparing as much healthy tissue as ...

Recommended for you

Study provides insight into link between two rare tumor syndromes

August 22, 2017
UCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation ...

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

August 22, 2017
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...

Study identifies miR122 target sites in liver cancer and links a gene to patient survival

August 22, 2017
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, ...

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

Searching for the 'signature' causes of BRCAness in breast cancer

August 21, 2017
Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature (a pattern of base swaps—e.g., Ts for Gs, Cs for As—throughout a genome) known in cancer genomics as "Signature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.